To Top

Search By Topic

Contract Development and Manufacturing (CDMO)

205 Articles available
Oncology

Holiday Program Brings Hope Home to Lung Cancer Patients

PR-M12-17-NI-002
Over-the-Counter

Men in the UK Will Be Able to Buy Viagra Over the Counter Next May

PAO-M12-17-NI-013
Packaging

Vetter Begins Construction of Packaging Facility Expansion

PAO-M12-17-NI-011
Immuno-oncology

Genentech and Biothera to Assess Combination Cancer Therapy

PAO-M12-17-NI-010
Drug Development

U.S. Patient Receives Kite’s Yescarta CART-T Therapy

PAO-M12-17-NI-008
Biosimilars

First Biosimilar to Treat Breast and Stomach Cancers Approved

PAO-M12-17-NI-007
Mergers & Acquistions

Five Critical Considerations for Pharmaceutical M&A

PAO-M12-17-Cl-001
Recognition

Vetter receives Corporate Health Award’s recognition of excellence

PR-M12-17-NI-001
Strategic Partnership

AstraZeneca Launches Strategic Joint Venture in China

PAO-M12-17-NI-005
Clinical Trial

Zika Vaccine Candidate Enters Phase I Trial

PAO-M12-17-NI-008
Strategic Partnership

Russia’s BIOCAD to Manufacture Biosimilars in North Africa

PAO-M12-17-NI-007
Cell and Gene Therapy

Brammer Bio Completes Renovations at Manufacturing Site in Massachusetts

PAO-M12-17-NI-006
Regenerative Medicine

International Society for Cellular Therapy Supports New FDA Policy Framework for Regenerative Medicine

PAO-M12-17-NI-004
Drug Development

Thermo Fisher Scientific’s Patheon Division to Manufacture Nasal Formulation for Evoke Pharma

PAO-M12-17-NI-003
Strategic Partnership

New Collaboration Targets the Development of Oligonucleotides

PAO-M12-17-NI-002
PAO-M12-17-NI-001

Amerisource Bergen Expands in the US with Acquisition of H.D. Smith

PAO-M12-17-NI-001
Adherence

Digital Technology Makes It into Medicines

PAO-M11-17-NI-044
Gene Editing

More Gene Editing Technology Being Developed by Novartis

PAO-M11-17-NI-043
Partnership

Alcami to Produce Clinical Supplies of Darinaparsin for Solasia

PAO-M11-17-NI-042
Acquisition

Almac Expands Analytical Services with BioClin Laboratories Acquisition

PAO-M11-17-NI-033
Investment

FUJIFILM Plans $1 Billion Capacity Expansion in U.S., U.K.

PAO-M11-17-NI-029
Drug Development

Compugen Advances Lead Anti-TIGIT Monoclonal Antibody to Manufacturing

PAO-M11-17-NI-025
CDMO

Alcami to Manufacture Darinaparsin

PAO-M11-17-NI-016
FDA Approval

Calquence, AstraZeneca’s BTK Inhibitor Approved by FDA

PAO-M11-17-NI-001
Acquistion

Novartis Plans Acquisition of Advanced Accelerator Applications for $3.9 Billion

PAO-M10-17-NI-045
Biologics

ADCs: The Future of Biologic Drugs

PAP-Q04-17-VP-001
Capacity Expansion

Sanofi Expanding Manufacturing Capacity for Quadrivalent Influenza Vaccine

PAO-M10-17-NI-043
CAR-T

Breakthrough CAR-T Immunotherapy Approved

PAO-M10-17-NI-037
//Fix for text overflow in cards